Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2577)
All Articles published online
|
Nov 28, 2007 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ma WW, Hidalgo M. Exploiting novel molecular targets in gastrointestinal cancers. World J Gastroenterol 2007; 13(44): 5845-5856 [PMID: 17990350 DOI: 10.3748/wjg.v13.i44.5845] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i44/5845.htm |
| Number | Citing Articles |
| 1 |
Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Jacques Belghiti, Steven Curley, Yuman Fong, Gregory Gores, Robert Kerlan, Phillipe Merle, Bert O'Neil, Ronnie Poon, Lawrence Schwartz, Joel Tepper, Francis Yao, Daniel Haller, Margaret Mooney, Alan Venook. Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting. Journal of Clinical Oncology 2010; 28(25): 3994 doi: 10.1200/JCO.2010.28.7805
|
| 2 |
Dietmar W. Siemann. The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents. Cancer Treatment Reviews 2011; 37(1): 63 doi: 10.1016/j.ctrv.2010.05.001
|
| 3 |
Stephen Shuttleworth, Franck Silva, Cyrille Tomassi, Alexander Cecil, Thomas Hill, Helen Rogers, Paul Townsend. . Progress in Medicinal Chemistry 2009; 48: 81 doi: 10.1016/S0079-6468(09)04803-6
|
| 4 |
Gerhard Treiber. mTOR inhibitors for hepatocellular cancer: a forward-moving target. Expert Review of Anticancer Therapy 2009; 9(2): 247 doi: 10.1586/14737140.9.2.247
|
| 5 |
Sylvestor A. Moses, M. Ahad Ali, Song Zuohe, Lei Du-Cuny, Li Li Zhou, Robert Lemos, Nathan Ihle, A. Geoffrey Skillman, Shuxing Zhang, Eugene A. Mash, Garth Powis, Emmanuelle J. Meuillet.
In vitro and In vivo Activity of Novel Small-Molecule Inhibitors Targeting the Pleckstrin Homology Domain of Protein Kinase B/AKT. Cancer Research 2009; 69(12): 5073 doi: 10.1158/0008-5472.CAN-08-3839
|
| 6 |
Ayman O. Nasr, Mary F. Dillon, Susie Conlon, Paul Downey, Gang Chen, Adrian Ireland, Eamon Leen, David Bouchier-Hayes, Thomas N. Walsh. Acid suppression increases rates of Barrett’s esophagus and esophageal injury in the presence of duodenal reflux. Surgery 2012; 151(3): 382 doi: 10.1016/j.surg.2011.08.021
|
| 7 |
Henryk Dudek, Darren H Wong, Rokhand Arvan, Anee Shah, Kathleen Wortham, Bo Ying, Rohan Diwanji, Wei Zhou, Benjamin Holmes, Hailin Yang, Wendy A Cyr, Yi Zhou, Aalok Shah, Ruchir Farkiwala, Michael Lee, Yiting Li, Garrett R Rettig, Michael A Collingwood, Sujit K Basu, Mark A Behlke, Bob D Brown. Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo. Molecular Therapy 2014; 22(1): 92 doi: 10.1038/mt.2013.233
|
| 8 |
Paul Hasty, Carolina B. Livi, Sherry G. Dodds, Diane Jones, Randy Strong, Martin Javors, Kathleen E. Fischer, Lauren Sloane, Kruthi Murthy, Gene Hubbard, Lishi Sun, Vincent Hurez, Tyler J. Curiel, Zelton Dave Sharp. eRapa Restores a Normal Life Span in a FAP Mouse Model. Cancer Prevention Research 2014; 7(1): 169 doi: 10.1158/1940-6207.CAPR-13-0299
|
| 9 |
Wen Wee Ma, Joseph M. Herman, Antonio Jimeno, Daniel Laheru, Wells A. Messersmith, Christopher L. Wolfgang, John L. Cameron, Timothy M. Pawlik, Ross C. Donehower, Michelle A. Rudek, Manuel Hidalgo. A Tolerability and Pharmacokinetic Study of Adjuvant Erlotinib and Capecitabine with Concurrent Radiation in Resected Pancreatic Cancer. Translational Oncology 2010; 3(6): 373 doi: 10.1593/tlo.10196
|
| 10 |
Michael A van Geer, Conny T Bakker, Naoya Koizumi, Hiroyuki Mizuguchi, John G Wesseling, Ronald PJ Oude Elferink, Piter J Bosma. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction <italic>in vivo</italic>. World Journal of Gastroenterology 2009; 15(22): 2754-2762 doi: 10.3748/wjg.15.2754
|
| 11 |
Chery Whipple, Murray Korc. Targeting angiogenesis in pancreatic cancer: rationale and pitfalls. Langenbeck's Archives of Surgery 2008; 393(6): 901 doi: 10.1007/s00423-008-0280-z
|
| 12 |
Kathrin Rupertus, Christian Dahlem, Michael D. Menger, Martin K. Schilling, Otto Kollmar. Rapamycin Inhibits Hepatectomy-Induced Stimulation of Metastatic Tumor Growth by Reduction of Angiogenesis, Microvascular Blood Perfusion, and Tumor Cell Proliferation. Annals of Surgical Oncology 2009; 16(9): 2629 doi: 10.1245/s10434-009-0564-8
|